Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United Kingdom
  4. London Stock Exchange
  5. GlaxoSmithKline plc
  6. News
  7. Summary
    GSK   GB0009252882

GLAXOSMITHKLINE PLC

(GSK)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

GlaxoSmithKline : GSK Consumer Healthcare to Start Shift Towards Recyclable Toothpaste Tubes

05/13/2021 | 11:12pm EDT


ę MT Newswires 2021
All news about GLAXOSMITHKLINE PLC
06/23GLAXOSMITHKLINEá : Aims for $46 Billion Sales by 2031, Cuts 2022 Dividend Foreca..
MT
06/23ADRs End Mostly Higher; XPeng, BioNTech Among Companies Actively Trading
DJ
06/23Health Care Drops On Growth-Sector Bias -- Health Care Roundup
DJ
06/23GLAXOSMITHKLINEá : Download the presentation slides PDF - 7.8MB
PU
06/23FTSE 100 Closed Down Despite Outperforming European Indexes
DJ
06/23European ADRs Edge Higher in Wednesday Trading
MT
06/23GLAXOSMITHKLINEá : Goldman Sachs remains its Buy rating
MD
06/23GLAXOSMITHKLINEá : JP Morgan sticks Neutral
MD
06/23GSK's drugs arm to get $11 billion booster from consumer spin-off
RE
06/23FACTBOX : How GSK plans to fire-up its cash balance post split
RE
More news
Financials
Sales 2021 33 154 M 46 267 M 46 267 M
Net income 2021 3 775 M 5 268 M 5 268 M
Net Debt 2021 21 561 M 30 088 M 30 088 M
P/E ratio 2021 20,4x
Yield 2021 5,65%
Capitalization 70 515 M 98 474 M 98 405 M
EV / Sales 2021 2,78x
EV / Sales 2022 2,61x
Nbr of Employees 94 066
Free-Float 92,3%
Chart GLAXOSMITHKLINE PLC
Duration : Period :
GlaxoSmithKline plc Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends GLAXOSMITHKLINE PLC
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 27
Last Close Price 1 409,20 GBX
Average target price 1 513,96 GBX
Spread / Average Target 7,43%
EPS Revisions
Managers and Directors
NameTitle
Emma N. Walmsley Chief Executive Officer & Executive Director
Iain James Mackay Chief Financial Officer & Executive Director
Jonathan Richard Symonds Non-Executive Chairman
Karenann K. Terrell Chief Digital & Technology Officer
Hal V. Barron Executive Director & Chief Scientific Officer
Sector and Competitors
1st jan.Capitalization (M$)
GLAXOSMITHKLINE PLC5.01%98 474
JOHNSON & JOHNSON3.34%430 876
ROCHE HOLDING AG11.75%324 905
PFIZER, INC.6.09%221 725
NOVARTIS AG2.56%209 282
ABBVIE INC.6.39%202 586